Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
05/24/2012 | US20120128782 Multicomponent Degradable Cationic Polymers |
05/24/2012 | US20120128727 Bacterial expression of an artificial gene for the production of crm197 and its derivatives |
05/24/2012 | US20120128723 Cancer specific antibody and cell surface proteins |
05/24/2012 | US20120128717 Influenza virus vaccine composition and methods of use |
05/24/2012 | US20120128713 Replication-Defective Flavivirus Vaccine Vectors Against Respiratory Syncytial Virus |
05/24/2012 | US20120128709 Expression of recombinant proteins |
05/24/2012 | US20120128707 Streptococcus pneumoniae proteins and nucleic acids |
05/24/2012 | US20120128705 C6orf167 peptides and vaccines containing the same |
05/24/2012 | US20120128704 Repertoire of allo-restricted peptide-specific t cell receptor sequences and use thereof |
05/24/2012 | US20120128700 Constructs for delivery of therapeutic agents to neuronal cells |
05/24/2012 | US20120128695 Teneurin c-terminal associated peptides (tcap) and methods and uses thereof |
05/24/2012 | US20120128684 Conserved Hemagglutinin Epitope, Antibodies to the Epitope and Methods of Use |
05/24/2012 | US20120128682 Apolipoprotein l- i variants and their use |
05/24/2012 | US20120128676 Muc1 antibodies |
05/24/2012 | US20120128669 Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hrsv) nanobody constructs for the prevention and/or treatment of respiratory tract infections |
05/24/2012 | US20120128663 Fc VARIANTS THAT EXTEND ANTIBODY HALF-LIFE |
05/24/2012 | US20120128652 Endolysin plyp40 |
05/24/2012 | US20120128643 Gene vector |
05/24/2012 | US20120128640 Heterocyclic compounds and expansion agents for hematopoietic stem cells |
05/24/2012 | US20120128635 Methods and compositions for treating hemophilia b |
05/24/2012 | US20120128631 Compositions and methods for kinase-mediated cytoprotection and enhanced cellular engraftment and persistence |
05/24/2012 | US20120128627 Il-17 homologous polypeptides and therapeutic uses thereof |
05/24/2012 | US20120128624 Recombinant Human Albumin-Granulocyte Macrophage Colony Stimulating Factor Fusion Protein With Long-Lasting Biological Effects |
05/24/2012 | US20120128591 Anti-fap antibodies and methods of use |
05/24/2012 | US20120125355 Transgenic Plants Comprising Constructs Encoding Phosphoenolpyruvate Carboxykinase and/or Pyruvate Orthophosphate Dikinase |
05/24/2012 | DE112009003515T5 Pflanzen mit gesteigerter abiotischer Stresstoleranz und/oder gesteigerten ertragsbezogenen Eigenschaften und Verfahren zur Herstellung derselben Plants with increased abiotic stress tolerance and / or increased yield-related traits and methods of making the same |
05/24/2012 | DE102010052941A1 Therapeutisches Protein Therapeutic protein |
05/24/2012 | CA2818548A1 Neutralizing anti-ccl20 antibodies |
05/24/2012 | CA2818486A1 Ncrna and uses thereof |
05/24/2012 | CA2818353A1 Methods and compositions for inducing an immune response to egfrviii |
05/24/2012 | CA2817964A1 Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viii |
05/24/2012 | CA2817933A1 New ethiological agent |
05/24/2012 | CA2817891A1 Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response |
05/24/2012 | CA2817751A1 Methods for producing recombinant proteins |
05/24/2012 | CA2817714A1 New saccharomyces cerevisiae strains |
05/24/2012 | CA2817707A1 New strains of saccharomyces cerevisiae |
05/24/2012 | CA2817355A1 Methods and compositions for modulating pd1 |
05/24/2012 | CA2816558A1 A collection and methods for its use |
05/23/2012 | EP2455495A2 Instrument for detecting bacteria, method of detecting bacteria and kit for detecting bacteria |
05/23/2012 | EP2455488A2 Methods and compositions for DNA manipulation |
05/23/2012 | EP2455486A1 Method for screening for diet providing production of milk having immunoregulatory action |
05/23/2012 | EP2455484A2 Method for producing fatty acid alkyl esters using microorganisms having oil-producing ability |
05/23/2012 | EP2455483A2 Disease resistant plants |
05/23/2012 | EP2455482A2 Disease resistant plants |
05/23/2012 | EP2455481A2 Disease resistant plants |
05/23/2012 | EP2455480A2 Disease resistant plants |
05/23/2012 | EP2455479A2 Disease resistant plants |
05/23/2012 | EP2455478A2 Disease resistant plants |
05/23/2012 | EP2455477A2 Disease resistant plants |
05/23/2012 | EP2455476A1 Disease resistant plants |
05/23/2012 | EP2455475A1 Disease resistant plants |
05/23/2012 | EP2455474A1 Disease resistant plants |
05/23/2012 | EP2455473A1 Disease resistant plants |
05/23/2012 | EP2455472A2 Plants with increased yield |
05/23/2012 | EP2455471A2 Methods for treating hypercholesterolemia |
05/23/2012 | EP2455470A1 Method for amplifying nucleic acid |
05/23/2012 | EP2455469A1 Nucleic acid molecule capable of binding to hmgb1, and use thereof |
05/23/2012 | EP2455468A2 Amylase variants |
05/23/2012 | EP2455467A1 Double-stranded oligonucleotides |
05/23/2012 | EP2455466A1 Dna fragment and pharmaceutical composition |
05/23/2012 | EP2455465A2 Amylase Variants |
05/23/2012 | EP2455464A1 High fidelity restriction endonucleases |
05/23/2012 | EP2455463A2 High fidelity restriction endonucleases |
05/23/2012 | EP2455456A1 Use of kinesin inhibitors in HIV infection treatment and a method for screening them |
05/23/2012 | EP2455454A1 Method for introducing a polynucleotide into plant protoplast cells |
05/23/2012 | EP2455399A2 Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof |
05/23/2012 | EP2455398A2 Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof |
05/23/2012 | EP2455397A1 Mutant ras polypeptide crystal |
05/23/2012 | EP2455394A2 A family of pesticidal proteins and methods for their use |
05/23/2012 | EP2455393A2 A family of pesticidal proteins and methods for their use |
05/23/2012 | EP2455392A2 A family of pesticidal proteins and methods for their use |
05/23/2012 | EP2455391A2 A family of pesticidal proteins and methods for their use |
05/23/2012 | EP2455390A1 Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof |
05/23/2012 | EP2454942A1 Method for improvement of foods utilizing -amylase |
05/23/2012 | EP2454940A2 Cropping systems for managing weeds |
05/23/2012 | EP2454386A1 Influenza detection method and kit therefor |
05/23/2012 | EP2454379A1 Nucleic acid expression construct and its use as a cell proliferation marker |
05/23/2012 | EP2454378A1 Methods and systems for dna isolation on a microfluidic device |
05/23/2012 | EP2454376A2 Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts |
05/23/2012 | EP2454374A1 Oral vaccines produced and administered using edible micro-organism |
05/23/2012 | EP2454373A1 Enhancement of cellular production through mechanotransduction |
05/23/2012 | EP2454372A2 Treatment and diagnosis of immune disorders |
05/23/2012 | EP2454371A2 Chemical modification of small hairpin rnas for inhibition of gene expression |
05/23/2012 | EP2454370A1 Microrna-24 |
05/23/2012 | EP2454369A1 Modulation of factor 7 expression |
05/23/2012 | EP2454368A1 Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance |
05/23/2012 | EP2454367A2 Designer collagens and uses thereof |
05/23/2012 | EP2454365A2 Novel 9-elongase for production of polyunsaturated fatty acid-enriched oils |
05/23/2012 | EP2454284A2 Gram-positive bacteria specific binding compounds |
05/23/2012 | EP2454278A1 Novel fatty acid desaturases and elongases and uses thereof |
05/23/2012 | EP2454277A1 Regulation of zinc deficiency and tolerance in plants |
05/23/2012 | EP2454276A1 Therapeutic agents |
05/23/2012 | EP2454274A1 Viral vectors encoding a dna repair matrix and containing a virion-associated site specific meganuclease for gene targeting |
05/23/2012 | EP2453871A1 Orally administered bacteria as vehicles for systemic delivery of agents |
05/23/2012 | EP2453735A2 Dual vector for inhibition of human immunodeficiency virus |
05/23/2012 | EP2453731A1 Method for producing double haploid plants |
05/23/2012 | EP2407544A9 Production method for 1,3-propanediol using recombinant microbial strain having glycerol oxidation metabolic pathway blocked |
05/23/2012 | EP2247740B1 Genes encoding the biosynthetic pathway for etnangien production |
05/23/2012 | EP2107373B1 Analysis chip and analysis method |
05/23/2012 | EP2076598B1 Sirna and methods of manufacture |